Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.

Phase 4

Noven Therapeutics

Methylphenidate